Michael Scordo, Medical Oncologist and Hematologist at Memorial Sloan Kettering Cancer Center (MSKCC), shared on X:
“TCT Community, mark your calendars for one of the most unique conferences of the year. Insightful, practical, and forward-thinking topics focused on improving the tolerability (on all levels) of our therapies.
You can also submit an abstract of your work to present at the conference.”
Source: Michael Scordo/X